[시장보고서]체외진단(IVD) 동향과 시장 업데이트(2025년)

체외진단(IVD) 동향과 시장 업데이트(2025년)

In Vitro Diagnostic (IVD) Trends and Market Update, 2025

상품코드 : 1891758

리서치사 : Kalorama Information

발행일 : 2025년 12월

페이지 정보 : 영문 98 Pages

라이선스 & 가격 (부가세 별도)

한글목차

샘플 요청 목록에 추가

Kalorama Information의 "체외진단(IVD) 동향과 시장 업데이트(2025년)" 보고서는 세계 경제의 불확실성 속에서 진화하고 있는 IVD 시장에 대한 중요한 인사이트를 제공합니다. 본 보고서는 Kalorama의 핵심 연구인 "세계의 체외진단(IVD) 시장 제18판" 발표에 이어 연 2회(4월, 12월) 발간되며, 진단 업계 의사결정권자를 위한 독립적인 정보원이자 전략적인 보조 자료로 활용될 수 있습니다.

2025년 IVD 시장은 기술 혁신과 의료 수요 증가에 힘입어 성장세를 이어갑니다. 차세대 염기서열분석(NGS), 미세유체기술, 정밀의료의 혁신은 진단을 혁신적으로 변화시키고 있으며, 암, 유전성 질환과 같은 복잡한 병태생리에 대한 고정밀, 고감도, 맞춤형 검사를 가능하게 하고 있습니다. 동반진단과 다중 검사의 급증은 환자 중심의 의료와 질병에 대한 이해의 심화로의 전환을 강조하고 있습니다.

업계가 주목하는 주요 성장 분야로는 현장진단, 암 진단, 동반진단 기술, 면역화학, 질량 분석 등이 있습니다. 핵산 검사, 유전자 검사, HPV 분자진단은 크게 확대될 것으로 예상되며, IVD의 미래를 형성할 것입니다.

본 보고서에서는 다음과 같은 실용적인 인사이트를 제공합니다:

시장의 시장 촉진요인 및 주요 산업 동향
혁신을 형성하는 신제품 개발
경쟁 상황과 주요 진출 기업의 전략
신흥 기회와 고성장 분야

Kalorama는 전문가 분석과 최신 데이터를 바탕으로 경영진, 업계 리더, 투자자들에게 규제 이슈에 대응하고, 기술 발전을 활용하며, 역동적인 IVD 분야에서 수익성 높은 기회를 파악할 수 있는 툴을 제공합니다.

영문목차

Kalorama Information's In Vitro Diagnostic (IVD) Trends and Market Update, 2025 delivers critical insights into the evolving IVD market amid global economic uncertainties. Published twice annually-in April and in December following the release of Kalorama's flagship study, The Worldwide Market for In Vitro Diagnostics (IVD), 18th Edition-this report serves as both a standalone resource and a strategic companion for decision-makers in the diagnostics industry.

The 2025 IVD market continues its growth trajectory, fueled by technological breakthroughs and rising healthcare demands. Innovations in next-generation sequencing (NGS), microfluidics, and precision medicine are transforming diagnostics, enabling highly accurate, sensitive, and personalized testing for complex conditions such as cancer and genetic disorders. The surge in companion diagnostics and multiplex testing underscores a shift toward patient-centric care and deeper disease insights.

Key growth segments attracting industry attention include Point-of-Care testing, cancer diagnostics, companion diagnostics technologies, immunochemistry, and mass spectrometry. Nucleic acid assays, gene testing, and HPV molecular diagnostics are poised for significant expansion, shaping the future of IVD.

This report provides actionable intelligence on:

Market drivers and major industry trends
New product developments shaping innovation
Competitive landscape and key player strategies
Emerging opportunities and high-growth segments

With expert analysis and up-to-date data, Kalorama equips executives, industry leaders, and investors with the tools to navigate regulatory challenges, capitalize on technological advancements, and identify profitable opportunities in the dynamic IVD sector.

Chapter 1: Worldwide IVD Market - December 2025 Update

About Kalorama Information
IVD Market Demand and Growth
- Figure 1-1: Q1-Q3 IVD Segment Performance Commentary, 2025 [Clinical Chemistry, Coagulation, Hematology, Histology, Immunoassay, Microbiology (Molecular), Point-of-Care (POC)]
- Table 1-1: Global In Vitro Diagnostic Sales by Product Market, 2025 ($ million) [Blood Bank Molecular - NAT Screens; Blood Grouping/Typing; Circulating Tumor Cells; Clinical Chemistry; Coagulation (PT/INR); Coagulation, Molecular; D-dimer; Diabetes HbA1c, lab; Drugs of Abuse; Hematology - Core Lab; Histology/Cytology; HPV, Molecular; Immuno - Blood Bank Screening; Immuno-Infectious Disease; Immunoassays - Non-isotopic; Mass Spectrometry; Microbiology (ID/AST); Microbiology (Molecular); Microbiology - Mass Spectrometry; NAAT - Oncology; Nucleic Acid Assays - Genetic/Inherited; Other Immunos; POC, OTC Diabetes; POC, OTC Other; POC, Professional/Hospital]
- Figure 1-2: IVD Segment Performance, Q1 2025-Q4 2025 estimated ($ million) [Clinical Chemistry, Coagulation, Hematology, Histology, Immunoassay, Microbiology, Point-of-Care (POC), Other]
- Figure 1-3: IVD Segment Performance, Total Market Value, 2025 estimated ($ million) [Clinical Chemistry, Coagulation, Hematology, Histology, Immunoassay, Microbiology, Point-of-Care (POC), Other]
- COVID-19 Diagnostic Markets
  - Table 1-2: COVID-19 Product Sales, 2025 ($ million) [Immunoassay (Antigen, Serology), Molecular, Rapid]
Effect of COVID-19 on Market Segments
- Table 1-3: IVD Market excluding and including COVID-19, 2025 ($ million)
- Figure 1-4: IVD Market Distribution, by Segment, 2025 (%) [COVID-19 Assays and Instruments, IVD Market excluding COVID-19 Assays and Instruments]
- Figure 1-5: IVD Market by COVID-19 and non-COVID markets, Quarterly Performance, 2025 estimated ($ million)
- Table 1-4: Global In Vitro Diagnostic Market - YoY Growth, 2024-2025 (%) [Blood Bank Molecular - NAT Screens, Blood Grouping/Typing, Circulating Tumor Cells, Clinical Chemistry, Coagulation (PT/INR), Coagulation, Molecular, D-dimer, Diabetes HbA1c, Lab, Drugs of Abuse, Hematology - Core Lab, Histology/Cytology, HPV, Molecular, Immuno - Blood Bank Screening, Immuno - Infectious Disease, Immunoassays- non-isotopic, Microbiology (ID/AST), Microbiology (Molecular), Microbiology - Mass Spectrometry, NAAT - Oncology, Nucleic Acid Assays - Genetic/Inherited, Other Immunos, POC, OTC Diabetes, POC, OTC Other, POC, Professional/Hospital]
- Figure 1-6: Global In Vitro Diagnostic Market - YoY Growth 2024-2025 (%) [Blood Bank Molecular - NAT Screens, Blood Grouping/Typing, Circulating Tumor Cells, Clinical Chemistry, Coagulation (PT/INR), Coagulation, Molecular, D-dimer, Diabetes HbA1c, Lab, Drugs of Abuse, Hematology - Core Lab, Histology/Cytology, HPV, Molecular, Immuno - Blood Bank Screening, Immuno - Infectious Disease, Immunoassays- non-isotopic, Microbiology (ID/AST), Microbiology (Molecular), Microbiology - Mass Spectrometry, NAAT - Oncology, Nucleic Acid Assays - Genetic/Inherited, Other Immunos, POC, OTC Diabetes, POC, OTC Other, POC, Professional/Hospital

Chapter 2: Product Trends and New Developments

Selected New - Q3 2025 - Core IVD Product Launches, Developments and Trends
- Immunoassay
- Mass Spectrometry
- Molecular
- Personalized Medicine
- POC
- Coagulation
- Flow Cytometry
- Sequencing
Selected COVID-19 Developments - Q3 2025
- Antigen/Antibody
- Molecular

Chapter 3: Top IVD Market Participant Results

Selected Competitive Leader Updates
- Figure 3-1: IVD Segment Growth by Leading Competitors, Change in Sales 2024-2025 (%)
- Figure 3-2: Changes in Market Distribution for IVD Sales, 2022-2025 estimated (%)
- Figure 3-3: Comparison of Total Diagnostic Sales for Abbott vs Roche, 2023-2025 estimated ($ million)
Q3 2025 M&A Activity
- Table 3-1: Q3 2025 Merger and Acquisition Activity
Abbott Laboratories
- Table 3-2: Abbott Corporate Summary
Becton Dickinson and Co
- Table 3-3: Becton Dickinson Corporate Summary
bioMerieux SA
- Table 3-4: bioMerieux Corporate Summary
Danaher Corporation
- Table 3-5: Danaher Corporation Summary
Dexcom, Inc
- Table 3-6: Dexcom Corporate Summary
Exact Sciences
- Table 3-7: Exact Sciences Corporate Summary
Roche Diagnostic
- Table 3-8: Roche Diagnostic Corporate Summary
Siemens Healthineers
- Table 3-9: Siemens Healthineers Corporate Summary
Sysmex Corporation
- Table 3-10: Sysmex Corporate Summary
Thermo Fisher Scientific
- Table 3-11: Thermo Fisher Scientific Corporate Summary

Chapter 4: New Opportunities

Personalized Medicine
Genetic Testing in Disease
Microbiome
IVD Digital Diagnostics
Tariffs

한글목차

목차

제1장 세계의 IVD 시장 - 2025년 12월 업데이트

제2장 제품 동향과 신개발

제3장 IVD 시장의 주요 기업 결과

제4장 새로운 기회

영문목차

Table of Contents

Chapter 1: Worldwide IVD Market - December 2025 Update

Chapter 2: Product Trends and New Developments

Chapter 3: Top IVD Market Participant Results

Chapter 4: New Opportunities